| Mr Alan Edward Wilson Jr, MD | |
|
925 Chestnut St Fl 5, Philadelphia, PA 19107-4206 | |
| (800) 321-9999 | |
| (267) 479-1321 |
| Full Name | Mr Alan Edward Wilson Jr |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 925 Chestnut St Fl 5, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053800490 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 25MA11731200 (New Jersey) | Secondary |
| 207X00000X | Orthopaedic Surgery | MD472832 (Pennsylvania) | Primary |
| Entity Name | Reconstructive Orthopaedic Associates Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861433278 PECOS PAC ID: 7416845318 Enrollment ID: O20040310000667 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the recent decision by the U.S. Food and Drug Administration (FDA) to grant approval of AstraZeneca's Seroquel XR for adjunctive treatment of major depressive disorder will not change Decision Resources' market forecast for the indication. As previously forecasted, Seroquel and Seroquel XR will garner nearly one quarter of antipsychotics sales as adjunctive treatments for major depressive disorder in 2013 in the world's major pharmaceutical markets.
The effects of Amyloid beta (Aβ)-Aβ-binding alcohol dehydrogenase (ABAD) may exacerbate Alzheimer's disease pathology.
Publication of the WOEST trial results reaffirm the study's major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy.
In a recent study, researchers target the electropositive receptor-binding domain (RBD) on the SARS-CoV-2 spike protein with the abundant β-sheet structure as a novel COVID-19 therapeutic drug design.
Utah advocates for children and low-income residents on Tuesday said that a federal waiver sought by the state that would allow more low-income families into the state's premium subsidy plan will, in effect, push out children now covered by SCHIP, the Salt Lake City Deseret News reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Alan Edward Wilson Jr, MD 833 Chestnut St Ste 520, Philadelphia, PA 19107-4430 Ph: (609) 677-7003 | Mr Alan Edward Wilson Jr, MD 925 Chestnut St Fl 5, Philadelphia, PA 19107-4206 Ph: (800) 321-9999 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the recent decision by the U.S. Food and Drug Administration (FDA) to grant approval of AstraZeneca's Seroquel XR for adjunctive treatment of major depressive disorder will not change Decision Resources' market forecast for the indication. As previously forecasted, Seroquel and Seroquel XR will garner nearly one quarter of antipsychotics sales as adjunctive treatments for major depressive disorder in 2013 in the world's major pharmaceutical markets.
The effects of Amyloid beta (Aβ)-Aβ-binding alcohol dehydrogenase (ABAD) may exacerbate Alzheimer's disease pathology.
Publication of the WOEST trial results reaffirm the study's major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy.
In a recent study, researchers target the electropositive receptor-binding domain (RBD) on the SARS-CoV-2 spike protein with the abundant β-sheet structure as a novel COVID-19 therapeutic drug design.
Utah advocates for children and low-income residents on Tuesday said that a federal waiver sought by the state that would allow more low-income families into the state's premium subsidy plan will, in effect, push out children now covered by SCHIP, the Salt Lake City Deseret News reports.
› Verified 5 days ago
Samir Mehta, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3737 Market St, 7 Floor, Philadelphia, PA 19104 Phone: 215-662-3340 Fax: 215-222-8875 | |
Patrick John Cahill, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 34th & Civic Center Blvd, Children's Hospital Of Philadelphia, Philadelphia, PA 19104 Phone: 215-590-1527 Fax: 215-590-1501 | |
Megan Elizabeth Gresh, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3601 A St, Philadelphia, PA 19134 Phone: 215-427-5000 | |
Nicolas Echeverria, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-2000 | |
Peter Francis Deluca, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 925 Chestnut St, Fl 5, Rothman Institute, Philadelphia, PA 19107 Phone: 267-339-3500 Fax: 215-503-0580 | |
Easwaran Balasubramanian, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-2111 Fax: 215-707-2324 | |
Dr. Theodore J Ganley, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 34th & Civic Center Blvd, Children's Hospital Of Philadelphia, Philadelphia, PA 19104 Phone: 215-590-1527 Fax: 215-590-1501 |